With 0.51 million shares changed hands, the volume of the stock remained lighter than its average volume of 0.77 million shares. During the session, the Diagnostics & Research company that operates in wider Healthcare sector, reached to the highest price of $47.845 whereas the lowest price it dropped to was $45.1. The 52-week range on TWST shows that it touched its highest point at $60.90 and its lowest point at $27.41 during that stretch. It currently has a 1-year price target of $53.09. Beta for the stock currently stands at 1.86.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of TWST was down-trending over the past week, with a drop of -3.85%, but this was down by -6.48% over a month. Three-month performance surged to 10.61% while six-month performance fell -2.35%. The stock gained 45.50% in the past year, while it has gained 1.85% so far this year. A look at the trailing 12-month EPS for TWST yields -3.60 with Next year EPS estimates of -1.66. For the next quarter, that number is -0.63. This implies an EPS growth rate of 37.45% for this year and 26.31% for next year.
Float and Shares Shorts:
At present, 58.88 million TWST shares are outstanding with a float of 56.19 million shares on hand for trading. On 2024-10-31, short shares totaled 9.02 million, which was 1540.0 higher than short shares on 1727654400. In addition to Dr. Emily Marine Leproust Ph.D. as the firm’s Co-Founder, Chairman & CEO, Dr. Patrick John Finn Ph.D. serves as its President & COO.
Institutional Ownership:
Through their ownership of 1.1012 of TWST’s outstanding shares, institutional investors have minority control over the company.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2024-06-30, TWST reported revenue of $84710000.0 and operating income of -$36043000.0. The EBITDA in the recently reported quarter was -$28066000.0 and diluted EPS was $nan.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for TWST since 7 analysts follow the stock currently. There are 7 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With TWST analysts setting a high price target of 60.0 and a low target of 35.0, the average target price over the next 12 months is 51.80909. Based on these targets, TWST could surge 26.77% to reach the target high and fall by -26.05% to reach the target low. Reaching the average price target will result in a growth of 9.46% from current levels.
Analysts have provided yearly estimates in a range of -$3.69739 being high and -$3.72721 being low. For TWST, this leads to a yearly average estimate of -$3.71727.
